Cicatrix Clinical Trial
Official title:
Observational Study for the Long-Term Effects of a Dermal Substitute on Patients With Facial Burns.
The aim of this observational study is to investigate the long-term (between 10-20 years)
results for the surgical treatment of third degree burn injury in the face and/or the neck by
means of Integra® Dermal Regeneration Template.
This study is an observational case-control study. The healthy skin of a comparable and/or
contralateral skin-site of the face/neck serves as a comparator.
The population consists of human volunteers between 18 and 75 years old with third degree
full thickness burn injuries in the face and/or neck, who underwent surgical treatment with
IDRT between 1998 and 2008.
Study Procedures
Description of the clinical-investigation-related procedures in order of occurrence.
All patients will respect a 30 minute acclimatisation period in the measurement room with
standardised room temperature (20-22°C) and relative humidity (40-50%). Patients will be
asked to remove their silicones and pressure garments the evening before the actual
measurement. The scar site used for testing is marked with a circular adhesive marking with a
diameter of 30 mm. A picture is taken to establish the location. The following optimal
patient positions are recommended. The patient is lying on his back with the arms next to the
body.
Order of occurrence:
1. Intake questionnaire
2. Digital photographs and video recording
3. Patient and Observer Scar Assessment
4. Colour measurement
5. TEWL measurement
6. Elasticity measurement
7. Thickness measurement
8. Quality of Life questionnaires
Intake Questionnaire
Patient will be asked to fill out an intake form with all relevant information for the study.
This will include age, body weight, gender, ethnicity, date of surgery, smoking, scar
revision or initial treatment,
Digital Photographs and Video Recording
A digital photograph will be taken from the patient's face and/or neck. This photograph will
be taken from a standardised distance. A video recording will be made to capture the mimic of
the patient.
Patient and Observer reported Scar Assessment Scale (PSAS-OSAS)
The POSAS aims to measure scar quality. Current developments in scar treatment necessitate
reliable and valid scar assessment tools. The POSAS is a comprehensive scale that is designed
for the evaluation of all types of scars by professionals and patients. The Patient Scale
gives the POSAS an important extra dimension because the patient's opinion is mandatory for a
complete scar evaluation. When patients indicated may update their opinion without having to
visit the hospital. This can be achieved at their convenience by internet or e-mail.
Clinimetric studies support the use of the POSAS for subjective scar evaluation. The first
publication on the POSAS (Version 1.0) was in 2004. With one extra item for the Observer
Scale and minor textual modifications POSASv2.0 was tested on linear scars and published in
2005.
The POSASv2.0 consists of two parts: a Patient Scale and an Observer Scale. Both scales
contain six items that are scored numerically on a ten-step scale from 1 (= healthy skin) to
10 (= worst imaginable scar). Together they make up the 'Total Sum of Scores' of the Patient
and Observer Scale. Furthermore category boxes are available to score nominal parameters
(e.g. type of colour). Moreover, the patient and observer also score their 'Overall Opinion'.
Colour measurement with Mexameter® (Courage & Khazaka GmbH, Cologne, Germany)
Light is generated by a source lamp and is dispersed into its constituent wavelengths in a
monochromator which results in a narrow band of the dispersed spectrum passing from the exit
slit of the device. Suitable optics is used to lead this light, of a narrow wavelength band,
to the sample being measured. A sample with an UV/Visible chromophore sample absorbs a
certain amount of light and a suitable detector in the spectrophotometer detects the
remaining light. The Beer-Lambert law is then applied to determine the concentration of the
remaining light in the sample at a specific wavelength. The most commonly used wavelengths
are 568 nm (green), 660 nm (red) and 880 nm (infrared). A melanin index can be computed from
the results of red and infrared wavelengths and an erythema index is calculated from the
results of green and red wavelengths.
TEWL measurements with Tewameter TM300® (Courage & Khazaka GmbH, Cologne, Germany)
The Tewameter® TEWL-probe is an open chamber system that measures water vapor permeability
according to the diffusion principle. A probe, consisting of an open hollow cylinder of 20mm
height and 10mm diameter measures the water evaporation gradient. Two sets of humidity and
temperature sensors are placed in a measurement chamber at different heights above the
scar/skin surface. At both points the local relative humidity and temperature are measured
and the corresponding vapor pressure is calculated. The difference between the vapor pressure
at both points is directly related to the rate of evaporative water loss. Results are
expressed in g/m2/h.
Elasticity measurements with Cutometer® MPA580 (Courage & Khazaka Gmbh, Köln, Germany)
The Cutometer® is designed to measure elasticity of the upper skin layer using negative
pressure which mechanically deforms the skin. The measuring principle is based on the suction
method. Negative pressure is created in the device and the skin is drawn into the aperture of
the probe and released again after a defined time. Inside the probe the penetration depth is
determined by a non-contact optical measuring system. This optical measuring system consists
of a light source and a light receptor and two prisms facing each other that project the
light from transmitter to receptor. The light intensity varies due to the penetration depth
of the skin. The resistance of the skin to the negative pressure (firmness) and its ability
to return to its original position (elasticity) are displayed as curves (penetration depth in
mm/time) in real time during the measurement. This measurement principle allows data
collection on the elastic and mechanical properties of skin surface and enables objective
quantification of skin aging. The Cutometer® measures the vertical deformation of the skin in
millimetres when the skin is pulled by means of a controlled vacuum into the circular
aperture of the probe.
Thickness measurement with DUB®Cutis High Frequency Ultrasound (Taberna Pro Medicum,
Lüneberg, Germany)
The DUB®Cutis skinscanner is a 22-MHz frequency ultrasound scanning system with 57 µm
resolution, a measuring depth of 10 mm and a 12,8 mm scan width. The system displays the
information obtained in the form of a B-scan as either a colour or gray-scale image. The DUB
system is an open system, preferably used with deionized water poured into the transducer
through a special hole. To avoid leaking the user has to press the probe to the skin during
the filling and the scanning procedure.
The result of ultrasonic imaging is usually presented in the form of A-scan (measurement at
one point, showing the thickness of different layers of the skin), B-scan two-dimensional
(2D) (cross-sectional view of the skin) and C-scan (2D) (view at some depth parallel to the
surface of the skin) images.
EQ5D Quality of Life Questionnaire
The EQ-5D was developed by the EuroQol Group, an international, cross-disciplinary group that
was set up in 1987 to investigate issues related to the evaluation of health. It has been
translated to more than 60 languages, is used worldwide and has previously been used in
Swedish populations. The reliability and validity of EQ-5D have been documented, both in
general and in burns-specific populations.
The EQ-5D descriptive system encompasses five questions covering five dimensions: mobility,
self-care, usual activities, pain and anxiety/depression. For each dimension, respondents
value their health by reporting whether they are experiencing 1 = ''none'', 2 = ''moderate''
or 3 = ''extreme problems''. A unique EQ-5D health state is defined by combining the
responses (1, 2 or 3) on each of the five dimensions. The EQ VAS is a vertical 20-cm line
graded from 0 = ''worst possible health state'' to 100 = ''best possible health state'', on
which the respondent is asked to mark his or her own current state of health. The EQ-5D
health state can also be converted into a weighted index. The conversion into the index is
based on norm values obtained in population-based enquiries. The EQ-5D index ranges from
0.594 = ''death or worse than death'' to 1 = ''full health''.
SF-36 Quality of Life Questionnaire
In development since the late 1980s, the SF-36 is a generic, psychometrically based,
self-rated questionnaire. No less than five versions are available for use though the second
(V2) and most recent format is the recommended option. It maps closely to the ICF domains and
has published gender and age stratified norms for grouped, condition specific and individual
comparisons. The SF-36 describes outcomes in terms of 8 separate subscales (domains) and
three summary measures incorporating the domain scores. The survey may be administered in the
standard or acute forms requesting responses in terms of recall of activity or feelings in
the previous 4 weeks or 1 week, respectively. The reliability and validity of the SF-36 have
been documented, both in general and in burns-specific populations.
Burn Specific Health Scale Brief (BSHS-B) Quality of Life Questionnaire
It is the only condition-specific health status instrument to be employed in patients with
burns. This questionnaire was designed to assess the level of functioning and health-related
QOL in adult burn survivors. The brief version (BSHS-B) was produced by Kildal et al. The
BSHS-B has 40 items covering nine well-defined domains. Responses are rated on a 5-point
scale from 0 (extremely) to 4 (none/not at all) for each of the 40 items and patients were
asked to select the best answer. Mean scores are calculated for each of the domains. This
final score reflects an alteration of the QOL. A higher mean score indicates a more positive
evaluation of function and higher QOL.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02645773 -
Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring
|
N/A | |
Completed |
NCT02672956 -
Comparison of Different Umbilical Port Entry Techniques in Terms of Cosmetic Results
|
N/A | |
Completed |
NCT00629811 -
Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women
|
Phase 2 | |
Completed |
NCT00847795 -
Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.
|
Phase 1/Phase 2 | |
Completed |
NCT00977951 -
Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03213548 -
Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty
|
N/A | |
Recruiting |
NCT05377723 -
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
|
N/A | |
Active, not recruiting |
NCT01976260 -
A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars
|
N/A | |
Terminated |
NCT00432328 -
Juvista (Avotermin) in Breast Reduction Surgery Scars
|
Phase 2 | |
Completed |
NCT00594581 -
Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males
|
Phase 2 | |
Completed |
NCT00984503 -
Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites
|
Phase 2 | |
Recruiting |
NCT04420442 -
Scar Resection and Reconstruction With Integra and Split Skin Grafts in Patients With Non-Suicidal Self-Inflicted Scars
|
N/A | |
Completed |
NCT02772289 -
Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars
|
Phase 2 | |
Completed |
NCT00430326 -
Juvista (Avotermin) in Scars Following Varicose Vein Removal
|
Phase 2 | |
Completed |
NCT00847925 -
Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects
|
Phase 1/Phase 2 | |
Recruiting |
NCT05787171 -
Three Sutures With Different Absorption Rates for Lower Abdominal Incision
|
N/A | |
Completed |
NCT02985151 -
Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy
|
N/A | |
Completed |
NCT02340325 -
FS2 Safety and Tolerability Study in Healthy Volunteers
|
Phase 1 | |
Active, not recruiting |
NCT00432211 -
Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.
|
Phase 2 | |
Completed |
NCT00978302 -
Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)
|
Phase 1 |